The assay originally obtained emergency use authorization in March 2020 and received EUA in October to allow sample pooling.
In a separate release, Euroimmun, a PerkinElmer company, launched an RUO SARS-CoV-2 interferon gamma release assay to determine the activity of T-cells reactive to SARS-CoV-2.
Pages: 1 2